Nonetheless, in a very controlled postmarketing discontinuation research of panic disorder clients who gained alprazolam, the length of therapy (three months in comparison to six months) had no impact on the power of individuals to taper to zero dose.Death is more normally connected with polysubstance use (Specifically benzodiazepines with other CN